# Beijing Hemu Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-hemu-biotechnology-co

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.hemubio.com/
- Total disclosed funding: $2.2M
- Latest round: Series A (Nov 4, 2025)
- Investors on record: 5

## About

Founded in 2022 and based in Beijing, China, Hemu Biotechnology is an animal vaccine manufacturer, focusing on the research and development of novel mRNA vaccines for animals. It has launched more than ten R&D pipelines, including vaccines for pigs, cattle, and pets, aiming to improve animal health protection. In November 2025, Hemu Biotechnology raised a series A funding from new investors Tianjin Changqing Group and Asia Green Fund.

The company provides animal vaccines. 

The company generates revenue from supplying animal vaccines. 

The company will use the latest funding to drive innovation in the vaccine industry and provide efficient solutions for the livestock and pet healthcare sectors.

## Funding rounds

- Series A, Nov 4, 2025 — Asia Green Fund, Tianjin Changqing Group
- Angel, Dec 13, 2022, $2.2M — Asia Green Fund, Innoangel Fund, Tianjin Yiyi Hygiene Products Co.,Ltd
- Angel, Oct 20, 2022 — Taiyou Fund, Innoangel Fund

## Investors

- Taiyou Fund — Angel
- Innoangel Fund (https://capitalatlas.ai/funds/innoangel-fund) — Angel
- Asia Green Fund (https://capitalatlas.ai/funds/asia-green-fund) — Angel, Series A
- Tianjin Yiyi Hygiene Products Co.,Ltd — Angel
- Tianjin Changqing Group — Series A